Vertigo Clinical Trial - Vestibular Evoked Myogenic Potentials in Benign

Status Completed

Clinical Trial Summary

Benign Paroxysmal Positional Vertigo (BPPV) is the most frequent cause of vertigo of peripheral vestibular origin with life time incidence of 2.4%. BPPV is characterized by bouts of acute whirling vertigo lasting less than one minute provoked by changes in head position in relation to the gravitational vector. The vertigo is accompanied by typical rotational or horizontal nystagmus that is often demonstrated by the Dix-Hallpike maneuver and less frequently by testing for positional nystagmus. BPPV pathogenesis is currently explained by the fall of otoconia (calcium-carbonate crystals) or otoconial debris from the tectorial membrane of the otolithic organs into the dependant semicircular canals (canalithiasis) or adherence of such particles to the semicircular canal's cupula (cupulithiasis). Under these circumstances, the semicircular canal which normally responds only to angular velocity and acceleration is stimulated by gravity. Otoconial remnants as free floating particles inside the semicircular canal arms or attached to the cupula have been observed by few investigators. Although the presence of such particles explains most characteristics of the positioning nystagmus described in BPPV, it does not account for the dizziness and disequilibrium which are described by many patients even without changes in head position and the continuation of such symptoms after successful treatment of BPPV as evidenced by the resolution of positional vertigo and nystagmus.

The study hypothesis is that otolithic pathology is an important component in the pathogenesis of BPPV explaining these symptoms, BPPV recurrence, and the refractoriness of some BPPV cases to the vastly employed particles repositioning treatments. In the present study the Vestibular Evoked Myogenic Potentials (VEMP) testing would be employed to measure the function of one of the otolithic organs - the saccule. The study objectives are: 1. To investigate possible malfunction of the saccule in patients suffering from BPPV. 2. To look for association between saccular pathology and BPPV recurrence and between such pathology and BPPV treatment failure. 3. To study possible relation between saccular pathology and continuation of dizziness and disequilibrium despite the resolution of positional vertigo.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01004913
Study type	Observational
Source	Meir Medical Center
Contact
Status	Completed
Phase	N/A
Start date	November 2009
Completion date	December 2011

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Recruiting	`NCT05533840` - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed	`NCT02533739` - Vestibular Disorder and Visuo-spatial Functions	N/A
Completed	`NCT01153789` - Study of Oculomotor Dysfunction Leading to Children Vertigo	N/A
Completed	`NCT00765635` - Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal	Phase 4
Not yet recruiting	`NCT04929444` - Training to Improve Vertigo Management in Primary Care	N/A
Completed	`NCT04458376` - Internet-based Self-help Program for Vestibular Rehabilitation in Chronic Dizziness	N/A
Not yet recruiting	`NCT04055766` - A Diagnostic Test on DeepDoc-an AI-based Decision Support System
Recruiting	`NCT06332326` - Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients	N/A
Completed	`NCT02938221` - Telemedical Examination of a Three-Component Oculomotor Testing Battery	N/A
Active, not recruiting	`NCT02655575` - Assessment and Treatment of Patients With Long-term Dizziness in Primary Care	N/A
Completed	`NCT02457455` - Urgent Medical and Surgical Conditions During Flights	N/A
Enrolling by invitation	`NCT01426932` - The Head Impulse Test in the Screening of Vestibular Function	N/A
Completed	`NCT00000359` - Treatments for Benign Paroxysmal Positional Vertigo (BPPV)	Phase 2
Not yet recruiting	`NCT06010550` - Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
Not yet recruiting	`NCT06017466` - Translation and Implementation of the Dutch VVAS Score in Clinical Practice	N/A
Completed	`NCT04598113` - Effect of Cervical Traction on Balance in Cervical Radiculopathy Patients	N/A
Completed	`NCT05157399` - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness	N/A
Completed	`NCT05897853` - Impact of Vertigoheel® on Patients Suffering From Bilateral Vestibulopathy and Functional Dizziness
Completed	`NCT05221892` - Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo (VEMP in BPPV)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms